Stock overview
Aktis Oncology Inc.
Explore the company, reported ownership, price history, and available source evidence.
AKTIS ONCOLOGY INC (AKTS) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $19.43
- · AKTS
- Tracked holders
- 4 funds
- Latest available 13F per fund
AKTS · USD
Price
$19.43
-$7.26
(-27.2%)
over selected range
Close · Sep 25, 2026
Market closed
23 stored daily closes
$19.43
Sep 25, 2026
- Range low
- $19.43
- Range high
- $27.05
- Observations
- 23
- Session date
- Sep 25, 2026
Aug 25, 2026–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $32,112,393 | 0.16% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | Newly reported 26'Q2 | $3,074,742 | 0% |
| Polen Capital Management position history Q2 2026 · filed Aug 4, 2026 · SEC filing | Newly reported 26'Q2 | $2,047,056 | 0.02% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | Newly reported 26'Q2 | $689,786 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market